Valeant Pharmaceuticals International Inc plans to raise its bid for Salix Pharmaceuticals Ltd close to $170 per share, a person familiar with matter told Reuters.Canada's Valeant is hoping to end a bidding war with Endo International Plc to acquire the bowel drug maker Salix.Valeant, which last month agreed to purchase Salix for $158 per share, or about $10 billion, aims to team up with Ackman's Pershing Square Capital Management and other top shareholders to raise its bid, the source said.The New York Times earlier reported Valeant's plan to raise its bid to above $160 per share. (nyti.ms/1BCpFBp)
Shares of ENDP fell by 3.5% or $-3.17/share to $87.33. In the past year, the shares have traded as low as $53.62 and as high as $92.80. On average, 3000360 shares of ENDP exchange hands on a given day and today's volume is recorded at 4632802.
Shares of ENL fell by 2.66% or $-3.08/share to $112.92. In the past year, the shares have traded as low as $59.50 and as high as $116.00. On average, 914 shares of ENL.TO exchange hands on a given day and today's volume is recorded at 336.
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company engaged in the prevention and treatment of gastrointestinal (GI) disorders. Shares of SLXP fell by 0.38% or $-0.65/share to $169.40. In the past year, the shares have traded as low as $86.00 and as high as $172.98. On average, 3022140 shares of SLXP exchange hands on a given day and today's volume is recorded at 7282518.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 2.5% or $4.81/share to $197.43. In the past year, the shares have traded as low as $106.00 and as high as $206.84. On average, 3083700 shares of VRX exchange hands on a given day and today's volume is recorded at 4785183.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.25% or $7.95/share to $252.29. In the past year, the shares have traded as low as $116.01 and as high as $263.91. On average, 417843 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 408224.
Source
